199 related articles for article (PubMed ID: 33914397)
21. Acute hemodynamic effects during immunoadsorption in patients with dilated cardiomyopathy positive for beta 1-adrenoceptor autoantibodies.
Christ T; Dobrev D; Wallukat G; Schüler S; Ravens U
Methods Find Exp Clin Pharmacol; 2001 Apr; 23(3):141-4. PubMed ID: 11523313
[TBL] [Abstract][Full Text] [Related]
22. Improvement of cardiac function after immunoadsorption in patients with dilated cardiomyopathy.
Felix SB; Staudt A; Friedrich GB
Autoimmunity; 2001; 34(3):211-5. PubMed ID: 11908780
[TBL] [Abstract][Full Text] [Related]
23. Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy.
Dörffel WV; Felix SB; Wallukat G; Brehme S; Bestvater K; Hofmann T; Kleber FX; Baumann G; Reinke P
Circulation; 1997 Apr; 95(8):1994-7. PubMed ID: 9133505
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic effect of immunoadsorption and subsequent immunoglobulin substitution in patients with dilated cardiomyopathy: Results from the observational prospective Bad Berka Registry.
Ohlow MA; Brunelli M; Schreiber M; Lauer B
J Cardiol; 2017 Feb; 69(2):409-416. PubMed ID: 27890513
[TBL] [Abstract][Full Text] [Related]
25. Immunoadsorption in dilated cardiomyopathy.
Felix SB
Ernst Schering Res Found Workshop; 2006; (55):353-61. PubMed ID: 16329672
[TBL] [Abstract][Full Text] [Related]
26. Immunomodulatory treatment strategies in inflammatory cardiomyopathy: current status and future perspectives.
Noutsias M; Pauschinger M; Poller WC; Schultheiss HP; Kühl U
Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):37-51. PubMed ID: 15038412
[TBL] [Abstract][Full Text] [Related]
27. Reduction of morbidity by immunoadsorption therapy in patients with dilated cardiomyopathy.
Knebel F; Böhm M; Staudt A; Borges AC; Tepper M; Jochmann N; Wernicke KD; Felix S; Baumann G
Int J Cardiol; 2004 Dec; 97(3):517-20. PubMed ID: 15561342
[TBL] [Abstract][Full Text] [Related]
28. [Immunoadsorption in a patient with dilated cardiomyopathy. The first case in Hungary].
Soltész P; Vass M; Diószegi Á; Mányiné Siket I; Garai I; Kun C; Bene O; Kertész A; Édes I
Orv Hetil; 2018 Apr; 159(13):526-530. PubMed ID: 29577764
[TBL] [Abstract][Full Text] [Related]
29. Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy.
Ameling S; Herda LR; Hammer E; Steil L; Teumer A; Trimpert C; Dörr M; Kroemer HK; Klingel K; Kandolf R; Völker U; Felix SB
Eur Heart J; 2013 Mar; 34(9):666-75. PubMed ID: 23100283
[TBL] [Abstract][Full Text] [Related]
30. Immunoadsorption therapy for dilated cardiomyopathy using tryptophan column-A prospective, multicenter, randomized, within-patient and parallel-group comparative study to evaluate efficacy and safety.
Yoshikawa T; Baba A; Akaishi M; Wakabayashi Y; Monkawa T; Kitakaze M; Izumi T; Tomoike H
J Clin Apher; 2016 Dec; 31(6):535-544. PubMed ID: 26801483
[TBL] [Abstract][Full Text] [Related]
31. Immunoadsorption in dilated cardiomyopathy.
Staudt A; Felix SB
Transfus Apher Sci; 2007 Oct; 37(2):187-90. PubMed ID: 18036989
[TBL] [Abstract][Full Text] [Related]
32. Immunoadsorption therapy in dilated cardiomyopathy.
Felix SB; Beug D; Dörr M
Expert Rev Cardiovasc Ther; 2015 Feb; 13(2):145-52. PubMed ID: 25494978
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic immunoadsorption--its role in clinical practice.
Braun N; Kadar JG; Risler T
Transfus Sci; 1998 Mar; 19 Suppl():65-9. PubMed ID: 10178698
[TBL] [Abstract][Full Text] [Related]
34. Immunoadsorption may provide a cost-effective approach to management of patients with inhibitors to FVIII.
Freedman J; Rand ML; Russell O; Davis C; Cheatley PL; Blanchette V; Garvey MB
Transfusion; 2003 Nov; 43(11):1508-13. PubMed ID: 14617307
[TBL] [Abstract][Full Text] [Related]
35. Immunoadsorption in a 40 year old man with dilated cardiomyopathy and underlying active myocarditis.
Müller II; Klingel K; Nikolaev VO; Jahns R; Gawaz MP; Weig HJ
Clin Res Cardiol; 2008 Oct; 97(10):787-90. PubMed ID: 18633566
[No Abstract] [Full Text] [Related]
36. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy.
Müller J; Wallukat G; Dandel M; Bieda H; Brandes K; Spiegelsberger S; Nissen E; Kunze R; Hetzer R
Circulation; 2000 Feb; 101(4):385-91. PubMed ID: 10653829
[TBL] [Abstract][Full Text] [Related]
37. A pilot study to assess the use of protein a immunoadsorption for chronic dilated cardiomyopathy.
Cooper LT; Belohlavek M; Korinek J; Yoshifuku S; Sengupta PP; Burgstaler EA; Winters JL
J Clin Apher; 2007; 22(4):210-4. PubMed ID: 17385721
[TBL] [Abstract][Full Text] [Related]
38. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study.
Felix SB; Staudt A; Dörffel WV; Stangl V; Merkel K; Pohl M; Döcke WD; Morgera S; Neumayer HH; Wernecke KD; Wallukat G; Stangl K; Baumann G
J Am Coll Cardiol; 2000 May; 35(6):1590-8. PubMed ID: 10807465
[TBL] [Abstract][Full Text] [Related]
39. Immunoadsorption as treatment option in dilated cardiomyopathy.
Felix SB; Staudt A
Autoimmunity; 2008 Sep; 41(6):484-9. PubMed ID: 18781476
[TBL] [Abstract][Full Text] [Related]
40. ABO-incompatible kidney transplantation using regenerative selective immunoglobulin adsorption.
Teschner S; Stippel D; Grunenberg R; Beck B; Wahba R; Gathof B; Benzing T; Burst V
J Clin Apher; 2012; 27(2):51-60. PubMed ID: 22271603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
